Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Charles Daley

Concepts (459)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Mycobacterium Infections, Nontuberculous
92
2025
378
16.690
Why?
Mycobacterium abscessus
36
2025
111
8.620
Why?
Mycobacterium avium-intracellulare Infection
27
2025
64
8.450
Why?
Mycobacterium avium Complex
42
2025
90
8.080
Why?
Nontuberculous Mycobacteria
50
2024
228
6.860
Why?
Lung Diseases
42
2025
723
6.720
Why?
Anti-Bacterial Agents
62
2025
1671
5.850
Why?
Antitubercular Agents
38
2024
197
5.630
Why?
Tuberculosis
32
2024
276
5.160
Why?
Tuberculosis, Pulmonary
25
2021
137
4.470
Why?
Tuberculosis, Multidrug-Resistant
13
2024
57
3.490
Why?
Mycobacterium Infections
12
2019
62
3.390
Why?
Mycobacterium kansasii
10
2020
12
3.100
Why?
Mycobacterium
15
2023
111
2.850
Why?
Bronchiectasis
18
2025
110
2.770
Why?
Mycobacterium tuberculosis
26
2019
314
2.740
Why?
Cystic Fibrosis
20
2023
1063
2.660
Why?
Amikacin
16
2025
23
2.580
Why?
Macrolides
15
2023
62
2.430
Why?
Drug Resistance, Bacterial
21
2023
173
2.070
Why?
Interferon-gamma Release Tests
6
2016
32
1.910
Why?
Sputum
25
2020
304
1.630
Why?
Microbial Sensitivity Tests
25
2025
336
1.620
Why?
Disease Outbreaks
6
2024
343
1.500
Why?
Humans
192
2025
129116
1.330
Why?
Latent Tuberculosis
8
2017
68
1.310
Why?
Pneumonia, Bacterial
6
2017
109
1.270
Why?
AIDS-Related Opportunistic Infections
4
2016
121
1.200
Why?
Clofazimine
4
2021
14
1.150
Why?
Antibiotics, Antitubercular
9
2021
36
1.140
Why?
Rifampin
14
2024
84
1.130
Why?
Pneumonia
5
2023
599
1.050
Why?
Clarithromycin
13
2023
26
0.970
Why?
Boron Compounds
1
2025
22
0.950
Why?
Drug Therapy, Combination
19
2022
1013
0.920
Why?
HIV Infections
15
2022
2710
0.900
Why?
Oxazolidinones
3
2013
13
0.900
Why?
Acetamides
3
2013
37
0.870
Why?
Global Health
8
2018
328
0.870
Why?
Ethambutol
10
2021
24
0.850
Why?
Tuberculin Test
6
2016
36
0.780
Why?
Equipment Contamination
2
2019
57
0.750
Why?
Aged
53
2025
22083
0.730
Why?
Treatment Outcome
31
2025
10226
0.720
Why?
Professional Practice Gaps
1
2020
14
0.700
Why?
Disease Management
4
2021
593
0.660
Why?
Middle Aged
60
2025
31074
0.650
Why?
San Francisco
10
2014
52
0.610
Why?
Molecular Epidemiology
4
2006
63
0.600
Why?
Adult
51
2025
35510
0.590
Why?
Female
76
2025
68510
0.580
Why?
Algorithms
1
2025
1621
0.560
Why?
Male
76
2025
63194
0.560
Why?
Practice Guidelines as Topic
7
2025
1493
0.530
Why?
Health Care Sector
2
2013
24
0.530
Why?
Extensively Drug-Resistant Tuberculosis
2
2013
6
0.520
Why?
Drug Resistance, Multiple, Bacterial
4
2019
66
0.510
Why?
United States
31
2025
13938
0.510
Why?
Lung
16
2024
3752
0.510
Why?
Azithromycin
6
2021
91
0.500
Why?
Phylogeny
5
2021
846
0.500
Why?
Imipenem
7
2024
15
0.500
Why?
Drug Synergism
5
2024
358
0.490
Why?
Genome, Bacterial
5
2021
134
0.480
Why?
Retrospective Studies
28
2022
14571
0.470
Why?
World Health Organization
3
2024
110
0.460
Why?
Linezolid
4
2018
20
0.460
Why?
beta-Lactamase Inhibitors
5
2024
6
0.450
Why?
Organ Transplantation
2
2024
219
0.440
Why?
Communicable Disease Control
1
2014
70
0.430
Why?
beta-Lactams
2
2024
26
0.420
Why?
Sex Factors
1
2019
1953
0.420
Why?
Serologic Tests
1
2012
50
0.410
Why?
Professional Practice
1
2012
64
0.390
Why?
Rifabutin
2
2012
6
0.380
Why?
Antibiotic Prophylaxis
1
2012
95
0.380
Why?
Opportunistic Infections
1
2011
47
0.370
Why?
Pyrazinamide
4
2021
10
0.370
Why?
Aged, 80 and over
15
2025
7064
0.350
Why?
Occupational Health
1
2013
196
0.340
Why?
Drug Administration Schedule
8
2025
758
0.340
Why?
Recurrence
10
2019
1003
0.330
Why?
Mass Screening
3
2016
1159
0.330
Why?
Occupational Exposure
1
2013
311
0.320
Why?
Administration, Inhalation
6
2021
664
0.320
Why?
Incidence
10
2019
2635
0.310
Why?
Cardiac Surgical Procedures
3
2019
492
0.310
Why?
Antigens, Bacterial
5
2012
120
0.290
Why?
Directly Observed Therapy
2
2005
14
0.290
Why?
Azabicyclo Compounds
2
2024
6
0.280
Why?
Europe
3
2025
362
0.280
Why?
Cefoxitin
3
2024
7
0.280
Why?
Cefuroxime
2
2024
4
0.280
Why?
Carcinoma, Squamous Cell
1
2012
621
0.280
Why?
Disease Progression
7
2025
2613
0.280
Why?
Health Personnel
3
2014
649
0.280
Why?
Tuberculosis, Pleural
2
2003
6
0.280
Why?
Quality of Life
6
2025
2693
0.280
Why?
Tomography, X-Ray Computed
9
2020
2541
0.270
Why?
Cephalosporins
2
2024
35
0.260
Why?
Morbidity
2
2019
302
0.260
Why?
Genomics
4
2021
716
0.250
Why?
Administration, Oral
4
2025
759
0.250
Why?
Diarylquinolines
2
2019
12
0.250
Why?
Antibodies, Monoclonal
1
2012
1359
0.250
Why?
ROC Curve
4
2020
502
0.250
Why?
Nebramycin
1
2025
1
0.250
Why?
Oxazepines
2
2025
5
0.240
Why?
Mutation
5
2019
3700
0.240
Why?
Diagnostic Tests, Routine
2
2019
103
0.240
Why?
Benzoxazoles
2
2025
19
0.240
Why?
Prospective Studies
14
2023
7079
0.240
Why?
Disease Transmission, Infectious
1
2005
57
0.240
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2025
46
0.230
Why?
Water Microbiology
1
2005
85
0.230
Why?
DNA Fingerprinting
1
2004
25
0.230
Why?
Contact Tracing
1
2004
23
0.230
Why?
Research
2
2018
410
0.230
Why?
Risk Factors
9
2019
9767
0.230
Why?
Arizona
1
2024
78
0.220
Why?
Alveolitis, Extrinsic Allergic
1
2005
92
0.220
Why?
Boronic Acids
1
2024
37
0.220
Why?
Self Administration
1
2004
122
0.220
Why?
DNA, Bacterial
3
2021
324
0.220
Why?
Biomedical Research
5
2020
647
0.220
Why?
Mexico
1
2024
190
0.220
Why?
Medical Tourism
1
2023
9
0.210
Why?
Colorado
5
2024
4394
0.210
Why?
Adolescent
18
2025
20301
0.210
Why?
Registries
5
2020
1884
0.210
Why?
Biomarkers
3
2020
3896
0.210
Why?
London
1
2023
45
0.210
Why?
Leprostatic Agents
1
2022
5
0.210
Why?
Stem Cell Transplantation
1
2024
165
0.210
Why?
Republic of Korea
6
2019
28
0.200
Why?
Pneumonectomy
2
2016
150
0.200
Why?
Dose-Response Relationship, Drug
4
2025
1945
0.200
Why?
Forced Expiratory Volume
6
2025
511
0.200
Why?
Lung Neoplasms
2
2012
2329
0.190
Why?
Meningitis
1
2023
80
0.190
Why?
Isoniazid
4
2019
60
0.190
Why?
Spectinomycin
1
2021
2
0.190
Why?
Thorax
1
2022
41
0.190
Why?
Time Factors
7
2020
6518
0.190
Why?
Young Adult
11
2025
12389
0.190
Why?
Radiography, Thoracic
3
2017
164
0.190
Why?
Comorbidity
4
2019
1546
0.190
Why?
Cohort Studies
8
2020
5407
0.180
Why?
Safety
1
2003
329
0.180
Why?
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
1
2020
6
0.180
Why?
Cluster Analysis
4
2020
478
0.180
Why?
Peptidyl Transferases
1
2020
7
0.180
Why?
Bacteriophages
1
2022
92
0.180
Why?
Serine Proteases
1
2020
20
0.170
Why?
Respiratory Therapy
1
2020
23
0.170
Why?
Prevalence
4
2019
2564
0.170
Why?
Follow-Up Studies
5
2020
4915
0.170
Why?
Area Under Curve
3
2020
282
0.170
Why?
Nitroimidazoles
1
2019
9
0.160
Why?
Mycobacterium fortuitum
1
2019
2
0.160
Why?
Oxazoles
1
2019
31
0.160
Why?
Durable Medical Equipment
1
2019
4
0.160
Why?
Cost of Illness
1
2021
289
0.160
Why?
Genotyping Techniques
1
2019
72
0.160
Why?
Bronchoscopy
1
2020
208
0.160
Why?
Patient Selection
1
2003
665
0.160
Why?
Anti-HIV Agents
3
2016
748
0.160
Why?
Genotype
6
2019
1832
0.150
Why?
DNA Gyrase
1
2018
12
0.150
Why?
Drug-Related Side Effects and Adverse Reactions
1
2021
256
0.150
Why?
Aza Compounds
2
2010
12
0.150
Why?
Hematopoietic Stem Cell Transplantation
1
2024
574
0.150
Why?
Tertiary Care Centers
1
2019
147
0.150
Why?
Hospitals
1
2023
632
0.150
Why?
Musculoskeletal Diseases
1
2019
69
0.150
Why?
Respiratory System Agents
1
2018
22
0.150
Why?
Patient Compliance
3
2011
562
0.150
Why?
Internationality
1
2019
148
0.150
Why?
Treatment Failure
3
2019
343
0.150
Why?
Tuberculosis Vaccines
2
2010
4
0.140
Why?
Biological Specimen Banks
1
2018
96
0.140
Why?
Liposomes
1
2018
168
0.140
Why?
Child
11
2024
20805
0.140
Why?
alpha 1-Antitrypsin Deficiency
1
2018
61
0.140
Why?
Salvage Therapy
1
2018
138
0.140
Why?
Pulmonary Medicine
1
2018
80
0.140
Why?
Elephants
1
2017
5
0.140
Why?
Fluoroquinolones
3
2018
37
0.140
Why?
Interferon-gamma
4
2007
762
0.140
Why?
Agammaglobulinemia
1
2017
33
0.140
Why?
Quinolines
2
2010
154
0.140
Why?
Databases, Genetic
1
2018
228
0.140
Why?
Prognosis
5
2020
3788
0.140
Why?
Sensitivity and Specificity
4
2020
1825
0.130
Why?
Kartagener Syndrome
1
2016
30
0.130
Why?
Surgical Equipment
1
2016
13
0.130
Why?
Immunologic Deficiency Syndromes
1
2016
62
0.130
Why?
Genes, Bacterial
1
2016
158
0.130
Why?
Levofloxacin
1
2016
20
0.130
Why?
Staphylococcal Infections
2
2018
380
0.130
Why?
Public Health
4
2016
486
0.130
Why?
Surgical Wound Infection
1
2019
282
0.130
Why?
Adrenal Cortex Hormones
1
2019
519
0.130
Why?
Cough
3
2023
116
0.130
Why?
Gene Expression Regulation
2
2020
2508
0.120
Why?
Gene Expression Profiling
2
2020
1689
0.120
Why?
Patient Outcome Assessment
1
2016
127
0.120
Why?
Disease Models, Animal
2
2024
3953
0.120
Why?
Clinical Trials as Topic
3
2020
1000
0.120
Why?
Chronic Disease
3
2023
1706
0.120
Why?
Drug Tolerance
1
2015
83
0.120
Why?
Guidelines as Topic
1
2016
261
0.120
Why?
Cross Infection
1
2016
196
0.120
Why?
Antiretroviral Therapy, Highly Active
2
2007
266
0.110
Why?
Sequence Analysis, DNA
2
2014
773
0.110
Why?
Genetic Variation
2
2021
934
0.110
Why?
DNA Transposable Elements
2
2006
119
0.110
Why?
Double-Blind Method
4
2025
1865
0.110
Why?
Patient Acceptance of Health Care
2
2018
767
0.110
Why?
CD4 Lymphocyte Count
2
2004
267
0.110
Why?
Computational Biology
1
2018
598
0.110
Why?
Societies, Medical
4
2020
749
0.110
Why?
Anti-Inflammatory Agents
1
2017
471
0.110
Why?
beta-Lactamases
2
2024
34
0.110
Why?
MicroRNAs
1
2020
677
0.110
Why?
Patient-Centered Care
1
2018
493
0.100
Why?
Glucocorticoids
1
2017
575
0.100
Why?
Contraindications
1
2012
88
0.100
Why?
Transcriptome
2
2015
883
0.100
Why?
Models, Statistical
1
2016
626
0.100
Why?
Gene Expression Regulation, Bacterial
1
2015
322
0.100
Why?
Randomized Controlled Trials as Topic
1
2018
1363
0.100
Why?
Glycolipids
1
2012
42
0.100
Why?
Immunoenzyme Techniques
1
2012
206
0.100
Why?
Antibodies, Bacterial
1
2012
136
0.100
Why?
Cytokines
2
2011
1987
0.090
Why?
Drug Resistance, Multiple
1
2011
21
0.090
Why?
Consensus
3
2022
638
0.090
Why?
Chemical and Drug Induced Liver Injury
2
2003
134
0.090
Why?
Immunoglobulin A
1
2012
202
0.090
Why?
Drug Interactions
1
2012
360
0.090
Why?
Kaplan-Meier Estimate
3
2019
864
0.090
Why?
Pulmonary Disease, Chronic Obstructive
2
2018
953
0.090
Why?
Debridement
1
2011
87
0.090
Why?
Virulence
1
2011
254
0.090
Why?
Hospitals, General
2
2014
21
0.090
Why?
Metagenomics
2
2021
154
0.090
Why?
Bacterial Proteins
2
2024
826
0.090
Why?
Case-Control Studies
3
2020
3342
0.080
Why?
Respiratory Tract Infections
1
2014
372
0.080
Why?
Hepatitis, Viral, Human
1
2009
25
0.080
Why?
Netherlands
2
2012
77
0.080
Why?
Forkhead Transcription Factors
2
2007
182
0.080
Why?
Lung Transplantation
1
2012
276
0.080
Why?
Bacteriological Techniques
1
2009
70
0.080
Why?
Confidence Intervals
2
2015
319
0.080
Why?
Interleukins
2
2007
245
0.080
Why?
Vitamins
1
2010
174
0.080
Why?
Proportional Hazards Models
2
2019
1210
0.080
Why?
Hospitalization
1
2018
2077
0.080
Why?
Child, Preschool
4
2016
10450
0.080
Why?
Early Diagnosis
1
2009
236
0.080
Why?
Radiography
2
2008
865
0.070
Why?
Animals
7
2024
34600
0.070
Why?
Interleukin-9
1
2007
10
0.070
Why?
RNA, Ribosomal, 23S
2
2018
13
0.070
Why?
Logistic Models
3
2019
1979
0.070
Why?
Survival Analysis
2
2016
1265
0.070
Why?
Reagent Kits, Diagnostic
1
2007
44
0.070
Why?
Interleukin-12 Subunit p40
1
2007
9
0.070
Why?
Pneumonia, Pneumococcal
1
2007
40
0.070
Why?
Polysaccharides, Bacterial
1
2007
67
0.070
Why?
Congresses as Topic
2
2020
215
0.070
Why?
Th1 Cells
1
2007
136
0.070
Why?
Polymorphism, Single Nucleotide
3
2021
2065
0.070
Why?
Survivors
1
2010
463
0.070
Why?
Vitamin D
1
2010
381
0.070
Why?
Mice
4
2024
16644
0.060
Why?
Age Factors
3
2019
3120
0.060
Why?
Liver Function Tests
2
2003
109
0.060
Why?
Interleukin-8
1
2007
258
0.060
Why?
Immunosuppressive Agents
1
2009
690
0.060
Why?
Keratosis
1
2025
15
0.060
Why?
Regression Analysis
1
2008
984
0.060
Why?
Hydrotherapy
1
2005
8
0.060
Why?
Bacterial Load
1
2025
67
0.060
Why?
Coinfection
2
2018
133
0.060
Why?
Antirheumatic Agents
1
2007
282
0.060
Why?
Anti-Retroviral Agents
1
2007
230
0.060
Why?
Microbial Viability
1
2025
84
0.060
Why?
Surveys and Questionnaires
1
2017
5376
0.060
Why?
Cost-Benefit Analysis
2
2024
582
0.060
Why?
Mycobacterium xenopi
2
2014
2
0.060
Why?
Streptomycin
1
2003
16
0.060
Why?
Biopsy
2
2005
1086
0.060
Why?
Respiratory Function Tests
2
2016
583
0.060
Why?
Molecular Docking Simulation
1
2024
109
0.060
Why?
Carrier State
1
2004
60
0.050
Why?
Drug Evaluation, Preclinical
1
2024
168
0.050
Why?
Influenza, Human
1
2009
601
0.050
Why?
Medicare
2
2019
724
0.050
Why?
Dust
1
2023
99
0.050
Why?
Pseudomonas Infections
2
2016
213
0.050
Why?
Staphylococcus aureus
2
2018
431
0.050
Why?
Homosexuality, Male
1
2004
176
0.050
Why?
Substance Abuse, Intravenous
1
2004
106
0.050
Why?
Databases, Factual
2
2019
1279
0.050
Why?
Predictive Value of Tests
2
2007
1943
0.050
Why?
Tumor Necrosis Factor-alpha
1
2007
1192
0.050
Why?
Transplant Recipients
1
2024
151
0.050
Why?
Survival Rate
1
2007
1875
0.050
Why?
Los Angeles
1
2002
63
0.050
Why?
Drug Costs
1
2003
103
0.050
Why?
Lactams
1
2021
21
0.050
Why?
Peptidoglycan
1
2021
26
0.050
Why?
Amoxicillin
1
2022
30
0.050
Why?
Reproducibility of Results
2
2020
3033
0.050
Why?
Phenotype
2
2021
3058
0.050
Why?
Clone Cells
1
2021
255
0.040
Why?
Ambulatory Care
1
2005
506
0.040
Why?
Carboxypeptidases
1
2020
13
0.040
Why?
Real-Time Polymerase Chain Reaction
1
2021
326
0.040
Why?
Water
1
2023
444
0.040
Why?
Leukocyte Elastase
1
2020
74
0.040
Why?
Gene Ontology
1
2020
48
0.040
Why?
Multivariate Analysis
1
2003
1496
0.040
Why?
Chimera
1
2019
59
0.040
Why?
Drug Monitoring
2
2016
184
0.040
Why?
United States Food and Drug Administration
1
2020
198
0.040
Why?
Neutrophils
1
2025
1195
0.040
Why?
Medication Adherence
1
2024
569
0.040
Why?
Public Health Surveillance
1
2019
68
0.040
Why?
Stem Cells
1
2023
579
0.040
Why?
Cross-Over Studies
1
2021
513
0.040
Why?
Population Surveillance
1
2002
428
0.040
Why?
Risk Assessment
2
2019
3260
0.040
Why?
Mice, Inbred BALB C
1
2021
1230
0.040
Why?
Meat
1
2019
93
0.040
Why?
Molecular Diagnostic Techniques
1
2019
97
0.040
Why?
Ribosomal Proteins
1
2018
77
0.040
Why?
Prosthesis-Related Infections
1
2019
75
0.040
Why?
Insurance Claim Review
1
2018
72
0.040
Why?
Symptom Assessment
1
2019
127
0.040
Why?
Gene Regulatory Networks
1
2020
281
0.040
Why?
Gene Expression
2
2016
1462
0.040
Why?
International Cooperation
1
2018
173
0.040
Why?
Enzyme-Linked Immunosorbent Assay
2
2011
816
0.030
Why?
Animals, Zoo
1
2017
12
0.030
Why?
Methyltransferases
1
2017
69
0.030
Why?
Otitis
1
2016
9
0.030
Why?
Pseudomonas
1
2016
28
0.030
Why?
Drug Resistance, Microbial
1
2016
64
0.030
Why?
Immunoglobulins
1
2017
157
0.030
Why?
Delivery of Health Care
1
2023
894
0.030
Why?
Micronesia
1
2016
3
0.030
Why?
Mycobacterium chelonae
1
2016
9
0.030
Why?
Spirometry
1
2016
251
0.030
Why?
Needs Assessment
1
2018
361
0.030
Why?
Host-Pathogen Interactions
1
2019
348
0.030
Why?
Multiple Pulmonary Nodules
1
2016
19
0.030
Why?
Vital Capacity
1
2016
291
0.030
Why?
Body Temperature Regulation
1
2016
99
0.030
Why?
Bronchi
1
2017
240
0.030
Why?
Injections, Intravenous
1
2016
193
0.030
Why?
Clinical Decision-Making
1
2018
305
0.030
Why?
Drug Combinations
1
2016
329
0.030
Why?
Uganda
1
2015
72
0.030
Why?
Rhinitis
1
2016
148
0.030
Why?
Leukocytes, Mononuclear
2
2007
538
0.030
Why?
Fibrosis
1
2017
522
0.030
Why?
Insurance, Health
1
2016
271
0.030
Why?
RNA, Messenger
2
2015
2676
0.030
Why?
Research Design
1
2020
1040
0.030
Why?
Sinusitis
1
2016
202
0.030
Why?
Gastroesophageal Reflux
1
2016
232
0.030
Why?
Sequence Homology, Nucleic Acid
1
2013
150
0.030
Why?
False Positive Reactions
1
2014
114
0.030
Why?
Mycobacterium avium
1
2013
22
0.030
Why?
Greece
1
2012
7
0.030
Why?
DNA, Ribosomal Spacer
1
2012
6
0.030
Why?
Mycolic Acids
1
2012
7
0.030
Why?
Self Report
1
2017
806
0.030
Why?
Iran
1
2012
38
0.030
Why?
Bacterial Typing Techniques
1
2012
42
0.020
Why?
Geography
1
2013
186
0.020
Why?
Italy
1
2012
98
0.020
Why?
Sweden
1
2012
92
0.020
Why?
DNA-Directed RNA Polymerases
1
2012
57
0.020
Why?
Developing Countries
2
2005
285
0.020
Why?
Cerebrospinal Fluid
1
2012
89
0.020
Why?
Species Specificity
1
2013
570
0.020
Why?
Heat-Shock Proteins
1
2012
131
0.020
Why?
Protein Array Analysis
1
2011
56
0.020
Why?
Microspheres
1
2011
124
0.020
Why?
Drug Discovery
1
2012
130
0.020
Why?
Bone Marrow Cells
1
2012
294
0.020
Why?
Pseudomonas aeruginosa
1
2014
336
0.020
Why?
Adaptation, Physiological
1
2015
515
0.020
Why?
Referral and Consultation
1
2016
732
0.020
Why?
Demography
1
2011
277
0.020
Why?
Postoperative Care
1
2012
243
0.020
Why?
Body Mass Index
1
2019
2266
0.020
Why?
In Vitro Techniques
1
2012
1044
0.020
Why?
Evolution, Molecular
1
2014
467
0.020
Why?
RNA, Ribosomal, 16S
1
2012
521
0.020
Why?
Preoperative Care
1
2012
342
0.020
Why?
Hepatitis, Chronic
1
2009
5
0.020
Why?
Anxiety
1
2016
955
0.020
Why?
Fatty Acids
1
2012
415
0.020
Why?
Smoking
1
2016
1466
0.020
Why?
Pleural Diseases
1
2009
17
0.020
Why?
Age Distribution
1
2010
376
0.020
Why?
Sex Distribution
1
2010
359
0.020
Why?
Cross-Sectional Studies
2
2014
5068
0.020
Why?
Transcription, Genetic
1
2015
1403
0.020
Why?
Age of Onset
1
2010
494
0.020
Why?
Vulnerable Populations
1
2009
157
0.020
Why?
Molecular Sequence Data
1
2012
2819
0.020
Why?
False Negative Reactions
1
2007
51
0.020
Why?
Depression
1
2016
1292
0.020
Why?
Urinalysis
1
2007
72
0.020
Why?
Lymphatic Diseases
1
2007
21
0.020
Why?
Continuity of Patient Care
1
2009
279
0.020
Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2010
315
0.020
Why?
Longitudinal Studies
1
2014
2715
0.020
Why?
Bone Diseases
1
2007
61
0.020
Why?
Forced Expiratory Flow Rates
1
2006
15
0.020
Why?
Lung Diseases, Interstitial
1
2012
597
0.020
Why?
Clinical Laboratory Techniques
1
2007
94
0.020
Why?
Africa
1
2006
98
0.020
Why?
Infection Control
1
2007
134
0.020
Why?
Wounds and Injuries
1
2012
719
0.020
Why?
Skin Diseases
1
2007
142
0.010
Why?
India
1
2005
170
0.010
Why?
C-Reactive Protein
1
2007
397
0.010
Why?
Virus Latency
1
2005
77
0.010
Why?
Up-Regulation
1
2007
828
0.010
Why?
Anti-Infective Agents
1
2007
225
0.010
Why?
Dendritic Cells
1
2007
479
0.010
Why?
Quality of Health Care
1
2009
608
0.010
Why?
Cost Savings
1
2004
79
0.010
Why?
Diagnostic Techniques, Respiratory System
1
2003
5
0.010
Why?
Pleura
1
2003
22
0.010
Why?
Asthma
1
2016
2219
0.010
Why?
HIV Seronegativity
1
2003
25
0.010
Why?
Costs and Cost Analysis
1
2004
209
0.010
Why?
Pleural Effusion
1
2003
49
0.010
Why?
HIV Seropositivity
1
2003
119
0.010
Why?
Infant
1
2016
8992
0.010
Why?
Severity of Illness Index
1
2010
2739
0.010
Why?
Mice, Inbred C57BL
1
2012
5284
0.010
Why?
Chi-Square Distribution
1
2003
513
0.010
Why?
Clinical Protocols
1
2003
254
0.010
Why?
Hypertension, Pulmonary
1
2012
1741
0.010
Why?
Health Policy
1
2004
353
0.010
Why?
Rural Population
1
2005
512
0.010
Why?
Data Interpretation, Statistical
1
2003
335
0.010
Why?
Models, Theoretical
1
2004
546
0.010
Why?
Liver
1
2002
1833
0.010
Why?
Daley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)